Keywords: Brazil, Patent laws, Top-selling drugs, M&A, Attracting multinationals

Tougher drug patent regimes in Brazil, and need for emerging market growth, luring back western companies, says FT

Article | 16 November 2010

Some 30 years after they pulled out of the Brazil, western pharmaceutical companies are rushing back to expand and make acquisitions, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in